NASDAQ:NVCT | Free Cash Flow | Nuvectis Pharma, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2021-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$6.51M
2025-12-31-$3.97M
2025-03-31-$4.17M
2024-12-31-$2.47M
2024-03-31-$4.36M
2023-12-31-$3.85M
2023-03-31-$4.78M
2022-12-31-$3.52M
2022-03-31-$3.08M
2021-12-31-$1.07M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$16.01M
2024-12-31-$12.25M
2023-12-31-$15.95M
2022-12-31-$13.56M
2021-12-31-$9.5M